Cargando…

Antihypertensive drugs and risk of COVID-19?

Detalles Bibliográficos
Autores principales:	Tignanelli, Christopher J, Ingraham, Nicholas E, Sparks, Matthew A, Reilkoff, Ronald, Bezdicek, Tamara, Benson, Bradley, Schacker, Timothy, Chipman, Jeffrey G, Puskarich, Michael A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194709/ https://www.ncbi.nlm.nih.gov/pubmed/32222166 http://dx.doi.org/10.1016/S2213-2600(20)30153-3

Ejemplares similares

Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
por: Puskarich, Michael A., et al.
Publicado: (2021)

A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19
por: Lupei, Monica I., et al.
Publicado: (2022)

Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury: A Randomized Clinical Trial
por: Puskarich, Michael A., et al.
Publicado: (2022)

Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Antihypertensive drugs and risk of COVID-19?
por: Lo, Kevin Bryan, et al.
Publicado: (2020)

Antihypertensive drugs and risk of COVID-19?
por: Brown, Joshua D
Publicado: (2020)

We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity
por: Dutta, Nirjhar, et al.
Publicado: (2021)

Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
por: Ibrahim, Sherehan, et al.
Publicado: (2021)

Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
por: Lusczek, Elizabeth R., et al.
Publicado: (2021)

Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
por: Bramante, Carolyn T., et al.
Publicado: (2020)

Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals
por: Samorodnitsky, Sarah, et al.
Publicado: (2023)

Antihypertensive drugs and risk of COVID-19? – Authors' reply
por: Fang, Lei, et al.
Publicado: (2020)

Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
por: Bramante, Carolyn T, et al.
Publicado: (2021)

Antihypertensive drugs in COVID-19 infection
por: Pinto-Sietsma, Sara-Joan, et al.
Publicado: (2020)

A fast, resource efficient, and reliable rule-based system for COVID-19 symptom identification
por: Sahoo, Himanshu S, et al.
Publicado: (2021)

Fulminant hepatic failure in the setting of progressive ANCA-associated vasculitis associated with a rare alpha-1 antitrypsin phenotype, ’PiEE'
por: Reilkoff, Ronald, et al.
Publicado: (2018)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Sympathetic modulation by antihypertensive drugs
por: Katsurada, Kenichi, et al.
Publicado: (2021)

Rapid implementation of a medical student rotation in health systems operations and remote patient care in response to COVID-19
por: Hilliard, Brian, et al.
Publicado: (2022)

The association between antihypertensive drugs and glioma
por: Houben, M P W A, et al.
Publicado: (2006)

Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy
por: Zeng, Ming, et al.
Publicado: (2012)

Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
por: Cho, In-Jeong, et al.
Publicado: (2021)

Serum Levels of Acylcarnitines and Amino Acids Are Associated with Liberation from Organ Support in Patients with Septic Shock
por: Jennaro, Theodore S., et al.
Publicado: (2022)

Immunomodulation in COVID-19
por: Ingraham, Nicholas E, et al.
Publicado: (2020)

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
por: Veronesi, Maddalena, et al.
Publicado: (2007)

Use of Antihypertensive Drugs During Preeclampsia
por: Odigboegwu, Obinnaya, et al.
Publicado: (2018)

Measuring Adherence to Antihypertensive Drug Therapy
por: D'Souza, Anna
Publicado: (2004)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
por: Carlos-Escalante, José A., et al.
Publicado: (2021)

Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals
por: Bergman, Zachary R., et al.
Publicado: (2022)

A review on prescribing patterns of antihypertensive drugs
por: Jarari, Noah, et al.
Publicado: (2016)

Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis
por: Ren, Lu, et al.
Publicado: (2021)

Predictors of discharge disposition and mortality following hospitalization with SARS-CoV-2 infection
por: Ikramuddin, Farha, et al.
Publicado: (2023)

Antihypertensives: sex differences in risk of COVID-19
Publicado: (2021)

Incremental effects of antihypertensive drugs: instrumental variable analysis
por: Markovitz, Adam A, et al.
Publicado: (2017)

Preeclampsia in pregnancy and later use of antihypertensive drugs
por: Engeland, Anders, et al.
Publicado: (2015)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

Non-persistence to antihypertensive drug therapy in Lithuania
por: Treciokiene, Indre, et al.
Publicado: (2022)

The Impact of Non-Adherence to Antihypertensive Drug Therapy
por: Gardezi, Syed Karam Mustafa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9v711qa6op51oce8a9pos9ha6j